Neogen Class Action Lawsuit Filed
Analysis based on 6 articles · First reported Jul 18, 2025 · Last updated Aug 04, 2025
The class action lawsuit against Neogen, stemming from alleged misleading statements and poor integration with 3M's Food Safety Division, has led to significant drops in Neogen's stock price. This event highlights the risks associated with corporate mergers and the importance of transparent financial reporting, potentially impacting investor confidence in similar M&A activities.
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Neogen and its executives for alleged violations of the Securities Exchange Act of 1934. The lawsuit claims that Neogen made false and misleading statements regarding the integration of 3M's Food Safety Division, which Neogen acquired in September 2022. Investors were allegedly led to believe the integration was progressing well, despite undisclosed inefficiencies. Neogen later revealed a $461 million goodwill impairment charge, cut its fiscal year 2025 revenue and EBITDA guidance, and reported material weaknesses in internal control. Subsequent financial results showed further losses and revenue decline, leading to CEO John Adent stepping down. These revelations caused significant drops in Neogen's stock price, with investors now having until September 16, 2025, to seek lead plaintiff appointment.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard